Titre (en)
Checkpoint
Istex
Racine
Checkpoint
Istex
Exploration
Accueil
Racine
Racine

Serveur d'exploration sur la visibilité du Havre - Checkpoint (Istex)

Index « Titre (en) » - entrée « syndrome »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
syncytial < syndrome < syndromes  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 17.
Ident.Authors (with country if any)Title
000019 (2013) J. E. Gottenberg [France] ; P. Ravaud ; X. Puechal [France] ; V. Le Guern [France] ; J. Sibilia [France] ; V. Goeb ; C. Larroche ; J. J. Dubost ; S. Rist ; A. Saraux ; V. Devauchelle ; J. Morel ; G. Hayem [France] ; E. Hachulla ; A. Perdriger ; D. Sene [France] ; C. Zarnitsky [France] ; E. Perrodeau ; D. Batouche [France] ; V. Furlan ; J. Benessiano [France] ; R. Seror [France] ; X. Mariette [France]OP0114 Inefficacy of Hydroxychoroquine in Primary Sjögren’s Syndrome: Results at 12 Months of the Randomized Placebo-Controlled Trial of Plaquenil in Primary Sjögren’s Syndrome
000020 (2013) R. Seror ; T. Lazure [France] ; F. Desmoulins ; S. Pavy ; C. Miceli-Richard ; P. Ravaud ; X. MarietteOP0113 Modification of Salivary Gland Lymphocyte Pattern after Belimumab in Primary Sjogren’s Syndrome: Results of the Beliss Study
000021 (2013) G. Cinquetti ; C. Larroche ; B. Combe ; E. Hachulla ; O. Meyer [France] ; E. Pertuiset ; G. Kaplanski [France] ; X. Mariette [France] ; J.-E. Gottenberg [France]OP0066 Efficacy of rituximab in systemic manifestations of patients with primary sjÖgren’s syndrome: Results from the air registry
000022 (2013) V. Devauchelle-Pensec ; X. Mariette [France] ; S. Jousse-Joulin ; J.-M. Berthelot ; A. Perdriger ; E. Hachulla ; X. Puéchal ; V. Le Guern [France] ; J. Sibilia [France] ; J.-E. Gottenberg [France] ; L. Chiche [France] ; V. Goeb ; G. Hayem [France] ; J. Morel ; C. Zarnitsky [France] ; J.-J. Dubost ; J.-O. Pers ; E. Nowak [France] ; A. SarauxOP0065 Tolerance and efficacy of rituximab in primary sjogren syndrome (TEARS): Results of a randomized controlled trial
000172 (2010) S. Saal [France] ; L. Faivre [France] ; Bernard Aral [France] ; N. Gigot [France] ; A. Toutain [France] ; L. Van Maldergem [Belgique] ; A. Destree [Belgique] ; I. Maystadt [Belgique] ; J-P Cosyns [Belgique] ; P-S Jouk [France] ; B. Loeys [Belgique] ; D. Chauveau [France] ; E. Bieth [France] ; V. Layet [France] ; M. Mathieu [France] ; J. Lespinasse [France] ; A. Teebi [Qatar] ; B. Franco [Italie] ; E. Gautier [France] ; C. Binquet [France] ; A. Masurel-Paulet [France] ; C. Mousson [France] ; J-B Gouyon ; F. Huet [France] ; C. Thauvin-Robinet [France]Renal insufficiency, a frequent complication with age in oral‐facial‐digital syndrome type I
000297 (2009) Christel Thauvin-Robinet [France] ; Brunella Franco [Italie] ; Pascale Saugier-Veber [France] ; Bernard Aral [France] ; Nadège Gigot [France] ; Anne Donzel [France] ; Lionel Van Maldergem [Belgique] ; Eric Bieth [France] ; Valérie Layet [France] ; Michèle Mathieu ; Ahmad Teebi [Qatar] ; James Lespinasse [France] ; Patrick Callier [France] ; Francine Mugneret [France] ; Alice Masurel-Paulet [France] ; Elodie Gautier [France] ; Frédéric Huet [France] ; Jean-Raymond Teyssier [France] ; Mario Tosi [France] ; Thierry Frébourg [France] ; Laurence Faivre [France]Genomic deletions of OFD1 account for 23% of oral‐facial‐digital type 1 syndrome after negative DNA sequencing
000367 (2008) Aurélie Garchet-Beaudron [France] ; Sophie Dreux [France] ; Nathalie Leporrier [France] ; Jean-François Oury [France] ; Françoise Muller [France]Second‐trimester Down syndrome maternal serum marker screening: a prospective study of 11 040 twin pregnancies
000517 (2006) Andréas Andreou [France] ; Aude Lamy [France] ; Valérie Layet [France] ; Daniel Cailliez [France] ; Françoise Gobet [France] ; Christian Pfister [France] ; Michel Menard [France] ; Thierry Frebourg [France]Early‐onset low‐grade papillary carcinoma of the bladder associated with Apert syndrome and a germline FGFR2 mutation (Pro253Arg)
000523 (2006) C. Thauvin-Robinet [France] ; M. Cossée [France] ; V. Cormier-Daire [France] ; L. Van Maldergem [Belgique] ; A. Toutain [France] ; Y. Alembik [France] ; E. Bieth [France] ; V. Layet [France] ; P. Parent [France] ; A. David [France] ; A. Goldenberg [France] ; G. Mortier [Belgique] ; D. Héron [France] ; P. Sagot [France] ; A M Bouvier [France] ; F. Huet [France] ; V. Cusin [France] ; A. Donzel [France] ; D. Devys [France] ; J R Teyssier [France] ; L. FaivreClinical, molecular, and genotype–phenotype correlation studies from 25 cases of oral–facial–digital syndrome type 1: a French and Belgian collaborative study
000606 (2004) B. Keren [France] ; A. Hadchouel [France] ; S. Saba [France] ; Y. Sznajer [France] ; D. Bonneau [France] ; B. Leheup [France] ; O. Boute [France] ; D. Gaillard [France] ; D. Lacombe [France] ; V. Layet [France] ; S. Marlin [France] ; G. Mortier [Belgique] ; A. Toutain [France] ; C. Beylot [France] ; C. Baumann [France] ; A. Verloes [France] ; H. Cavé [France]PTPN11 mutations in patients with LEOPARD syndrome: a French multicentric experience
000656 (2003) Françoise Muller [France] ; Sophie Dreux [France] ; Corinne Sault [France] ; Armelle Galland [France] ; Hugues Puissant [France] ; Gisèle Couplet [France] ; Catherine Lemay [France] ; Marie-Estelle Larcher [France] ; Gilles Renom [France]Very low alpha‐fetoprotein in Down syndrome maternal serum screening
000686 (2003) Françoise Muller [France] ; Clarisse Benattar [France] ; François Audibert [France] ; Nathalie Roussel [France] ; Sophie Dreux [France] ; Howard Cuckle [Royaume-Uni]First‐trimester screening for Down syndrome in France combining fetal nuchal translucency measurement and biochemical markers
000730 (2002) Françoise Muller [France] ; Didier Thibaud [France] ; Françoise Poloce [France] ; Marie-Christine Gelineau [France] ; Marguerite Bernard [France] ; Christine Brochet [France] ; Christine Millet [France] ; Jean-Yves Réal [France] ; Marc Dommergues [France]Risk of amniocentesis in women screened positive for Down syndrome with second trimester maternal serum markers
000835 (2001) Treatment of hepatorenal syndrome with albumin dialysis using the molecular absorbents recirculating system (MARS): characterisation of treatment dose delivered
000860 (2001) Improved renal function is associated with increased survival in patients with cirrhosis and type 1 hepatorenal syndrome (HRS) treated with terlipressin. A retrospective multicenter study
000887 (2001) I. Marie ; H. Levesque ; J. L. Tranvouez ; A. Franc Ois ; G. Riachi [France] ; N. Cailleux ; H. CourtoisAutoimmune hepatitis and systemic sclerosis: a new overlap syndrome?
000990 (2000) C. Duhamel [France] ; J. Mauillon [France] ; I. Berkelmans [France] ; A. Bourienne [France] ; J. L Tranvouez [France]Hepatorenal syndrome in cirrhotic patients: terlipressine is a safe and efficient treatment; propranolol and digitalic treatments: precipitating and preventing factors?

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/France/explor/LeHavreV1/Data/Istex/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i -k "syndrome" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i  \
                -Sk "syndrome" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/France
   |area=    LeHavreV1
   |flux=    Istex
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Title.i
   |clé=    syndrome
}}
Wicri

This area was generated with Dilib version V0.6.25.
Data generation: Sat Dec 3 14:37:02 2016. Site generation: Tue Mar 5 08:25:07 2024